Abby Burns (00:08): From Advisory Board, we're bringing you a Radio Advisory, your weekly download on how to untangle healthcare's most pressing challenges. I'm Abby Burns. The 2026 midterm elections took place on Tuesday, November 3rd, almost a week ago as of the time of this recording. As you know by now, the Democratic Party took control of both the House and the Senate. (00:28): A lot of history was made in this election, but my goal for this episode is to dig into what these historical results will actually mean for healthcare policy and policymaking, and ultimately what that will mean for you as a healthcare leader trying to make sense of it all. To help me sift through all the nuances here, I've brought Advisory Board health policy experts, Ben Palmer and Natalie Trebes back to the pod. Hey, Ben. Hey, Natalie. Natalie Trebes (00:52): Hey, Abby. Ben Palmer (00:54): Thanks for having me. Abby Burns (00:59): We are here to talk about midterm elections, and specifically the impacts on healthcare. Very quick refresh in case anyone has been living under a rock. The Democratic Party took control of both the House and the Senate in the 2026 midterms. They flipped at least seven Senate seats, some of them in historically very red states like Texas, South Carolina. We're still waiting on the official votes to be tallied in Mississippi, but that might flip as well. There's a lot to unpack with the implications of this election overall, to put it lightly. But I want to focus on what our listeners most need to know. So to start off our conversation, how big a deal was this election for healthcare? Ben Palmer (01:38): I would say the sort of take home point for me has been it is consequential, but it's not necessarily transformational. The Democrats won control of Congress, both the Senate and the House, that's a big deal. But Donald Trump is still the president. He still has veto power over anything that gets through the Senate. And the Democrats in the Senate, while they have the majority, they do not have a veto proof majority. So they can pass whatever bills they want that will forward their agenda, but those can ultimately be vetoed by the president. So it's important for purposes that we'll discuss of oversight and those types of things, but things are still law and they will remain law. Natalie Trebes (02:17): Consequential is still very important because a lot of the things that are going to impact the country are healthcare related. And so there will be very salient impacts in the healthcare space that the country is watching. And a lot of groundwork for where health policy goes from here is going to be laid in the actions that are taken. Abby Burns (02:38): So it's not just important for the next two years, but really for the next five, seven, 10 years ahead. Natalie Trebes (02:45): Yeah. I would probably reframe to consequential to set up for potential transformation. Ben Palmer (02:49): Yeah, yeah. I mean, yeah. Natalie Trebes (02:50): I like to have my cake both ways. Ben Palmer (02:52): Yeah. I think what's going to happen is you're going to see Democrats are going to get caught trying. They're going to pass agenda bills that they're going to force Trump to veto. And that I think is going to set up the 2028 conversation. There's been talk about potentially even getting a CBO score for some kind of Medicare For All legislation just to get the idea of what it would look like. Obviously that would be vetoed if it even passed. But again, that's sort of just setting the stage for what will be the priorities in the 2028 election. Abby Burns (03:22): There are certainly a lot of specific policy areas that we could get into today, and I definitely want to talk about some of them. But if we think a little bit bigger picture, Natalie, how do we expect Democrats to try and leverage the momentum and the position that they've gained in Congress? Natalie Trebes (03:38): Yeah. I think all leaders need to keep in mind that the Democrats have a really tough needle to thread in balancing and understanding what this mandate from the electorate is. And so they have both been, I think, given the message that people want the Trump administration held accountable. They want some reining in of the GOP policies that kind of made it through. And they also responded positively to some of the affordability and progressive messaging that was really clear about how to affect daily American life. And so that is both a accountability implementation management story, business as usual, continue to operate the government responsibility, but also make progress on some of those more progressive priorities. And those are a lot of different lanes to balance even though they all inform each other. Ben Palmer (04:26): Democrats know that they have that message from the electorate of we need you to address these affordability things, and perhaps even believe that the voters voted to move on from the Trump era or so, and just sort of focus on these practical day-to-day things. So what that looks like is these message bills that may get vetoed. Abby Burns (04:47): More of the foundation building for, like Natalie said before, a future platform. Ben Palmer (04:51): Yeah. Saying these are our priorities. They will not be passed, but if you give us more power in the future, then these are the things that we could tackle. Then there will be the day-to-day running the government thing. So for example, government funding runs out on December 11th for the continuing resolution. Unless some sort of budget bill gets passed before December 11th, which I'm skeptical would happen, but anything could happen, then most likely a continuing resolution gets passed. It kicks the can into 2027. (05:19): And then there will most likely be some sort of budget fight where Democrats will say, "Okay, we need the budget to pass. We need to fund the government. Nobody wants a government shutdown. So in order for us to pass some sort of budget, then we need these things." That could be bringing back the enhanced ACA subsidies or delaying Medicaid work requirements, or whatever it may be, but utilizing some of that leverage to enact their agenda. Abby Burns (05:47): Okay. So we've got message bills, we've got the budget fight. Are there any other vehicles or forums where we might see policy move? Ben Palmer (05:56): Yeah, I think there's two that come to mind. One, we mentioned the budget, that's must pass legislation. There's also some must pass legislation coming up in September. The FDA user fee, those need to be reauthorized. FDA user fee reauthorization has been used in the past to enact other regulations or rules around FDA. So it could be entirely possible that Democrats say, "Hey, we would like some transparency rules implemented," or something like that over an FDA run by RFK Jr., who I think a lot of Democrats are obviously very skeptical of and who will also probably be dragged into Congress a lot for oversight hearings. Abby Burns (06:34): Ben, when you say must pass legislation, what makes it must pass? Ben Palmer (06:38): So FDA user fees, FDA gets the vast majority of its revenue through these user fees that they charge drug makers or anyone applying for FDA approval. They make almost all of their revenue through these user fees. So if the user fees are not reauthorized by Congress, then FDA loses virtually all of its funding. So it has to be passed in order for there to be a properly functioning FDA. And so, much in the way that a budget has to be passed for there to be a properly functioning government, even during a government shutdown, there are things that continue, but the government is not functioning in the way that it is intended to. So that makes that must pass. Natalie Trebes (07:16): It's also a part of government that a lot of very important stakeholders have a lot of interest in it moving forward. And so it's not just like a random part of the government has stopped working, and just the FDA, which is highly important to the industry. Abby Burns (07:31): So Ben, when we're thinking about the message bills that you said are likely to get vetoed given the Democrats don't have a veto proof majority, then we've got this sort of whole bucket of must pass legislation that's either part of a potential budget fight, or just part of HHS functioning and doing business as usual. It seems as though both of those have or may have sort of a partisan tilt. I'm wondering if there are any sort of bipartisan areas of policy focus that we could expect progress on. Ben Palmer (07:58): Yeah, absolutely. I think that's the other way legislation gets passed in this upcoming Congress. There are some areas that have some bipartisan support. It seems that some kind of legislation on the No Surprises Act is probably going to happen. Both Republicans and Democrats have expressed concerns over the arbitration process. Pharmacy benefit manager legislation could also happen. It's not very often that someone like Josh Hawley and Elizabeth Warren create a bill together considering they are ideologically so on the opposite ends of the spectrum. Abby Burns (08:30): Senators from Kentucky and Massachusetts respectively. Ben Palmer (08:32): Yes. And again, Hawley, a very conservative Republican, Warren, a very progressive Democrat, and they both agreed and co-sponsored PBM legislation together in the past. Abby Burns (08:42): Natalie, do any other examples come to mind for you? Natalie Trebes (08:45): I think there are a lot of areas that have shared acknowledgement of some sort of problem, of some sort of need for action. And then from there on out, you have differences in what stakeholder are you kind of catering to, or more attentive to, or what is the ideological approach you want to take to that regulation? So that can be anything from AI. Obviously Congress is going to be confronted with, and this is beyond healthcare, but a lot of pressure to both regulate or not regulate AI activity. (09:18): I think interoperability, prior auth, those technical administrative burden areas are an area that there is a lot of bipartisan agreement of that as a problem. And it's a lot more about just driving forward stakeholder alignment activities and playing a convening forcing function. Medicare Advantage is also the other one I'd probably put on there, and that includes some of these issues we've already talked about, to have a whole range of extra attention from Congress. (09:45): And it has a lot of support from Congress, but also draws a lot of desire for reform, improvement, better accountability, and potentially could play into both the terrain of technical fixes and routine governance, but also be a platform for expanding into more changes. I've heard Senator Sanders talk about, not Medicare For All, he's already obviously talked about that, but lowering the Medicare eligibility age, adding vision and dental into it. And so the Medicare Advantage traditional Medicare tension is one that I think we'll see a lot of activity and interest from this Congress. Ben Palmer (10:20): I also want to mention, this may just be him being overly optimistic, but I did hear incoming Senator Abdul El-Sayed say in an interview that he believes the Senate could get to a veto-proof majority on some of the Medicaid cuts within 03BA because he thinks that Democratic senators could work with senators from very rural states with rural hospitals that are going to be hit hard by those Medicaid cuts, and therefore get a handful of them to vote with the Democrats and get to a veto-proof majority. He probably is being overly optimistic, but it at least follows logical sense that something like that could maybe happen. Natalie Trebes (10:58): And I think there's a really important point there as healthcare organizations try to read tea leaves and interpret the different moves. It has historically in the last decade been really hard to isolate an issue and vote on it alone. We tend to have to do these packages because that's the only way we have forced senators and representatives to get to the table and each get a little bit of their piece. (11:23): So that's why we have the kind of reconciliation bill approach because we do have these really very obvious, dramatic, easy to say work requirements in Medicaid, ACA subsidies, and those translate to the interests of a lot of voters that just swung the other way, and a lot of the GOP is interested in that. And we are in this moment of, I think, major party realignment on all sides. Everyone is trying to figure out what does a post-Trump administration GOP and Democrat party look like. (11:53): I don't want to predict that definitely we will see action on isolated issues, but I think it is weirdly a slightly more plausible environment for some of those to get more legs. I would put 5% more chance on it than before. I'm not saying it's dramatic. But the main point I want to make is that people tend to think that Congress can pick and choose the issues, and usually it all needs to get lumped together. Abby Burns (12:17): That actually brings me to a question. As we're talking through all of these policies, you've named some really big thorny areas, AI, PBMs, prior auth, interoperability, Medicare Advantage. That's a long list of very big complex topics. How much bandwidth does this Congress have to actually take action on these? Natalie Trebes (12:39): Well, let's also not forget that a huge number of the members of Congress are going to be new. So not only are we going to see majority shift, control of committees change, but also there's just going to have to be a reorientation, restarting the process of getting to know your representatives, teaching them about the complexities of healthcare. And one thing we found out about various members' awareness of healthcare is in the fight a couple years ago to put together OBBBA, some leaders didn't really understand EMTALA, and any listener from hospital side will know that that is a very important thing to understand when you're making health policy. So I think, even if the ideology is a little more aligned with where some of the industry would like support in dealing with federal cuts over all the healthcare, they're still going to have education and relationship building work to do. Abby Burns (13:29): One of the points that I've seen a lot in the past week since the election, and actually we should timestamp this conversation, especially since I know results are still coming in. So we are recording this conversation at about 12:30 Eastern on November 9th. In the last week, I've seen a lot made about how there are six incoming physicians that were elected last week, which is incredibly exciting, especially as we are talking about educating Congress and governors on the healthcare industry. What I would also say is deep understanding of medicine doesn't necessarily translate to deep understanding of our care delivery and financing system. So I think that education point is really important. Natalie Trebes (14:02): I think anyone listening who's been a physician joining a healthcare leadership team knows they have a lot of education they have to go through to enter the C-suite. Abby, the other piece of bandwidth I want to make sure we cover it is the bandwidth to also do the oversight duties. And there's a lot of legislation happening right now getting into implementation. And I've mentioned work requirements, a lot of other things coming out of OBBBA, and just the general approaches the Trump administration has taken to running HHS. (14:30): This shift into the majority in both chambers allows, not a perfect unilateral set of tools to the Democrats, but allows a lot more capability to investigate what's happening, to demand information, to attach some conditions on funding, which is very important. And also with the shift, they get double the staff on the committees dedicated to the Democrats now. So the capability to kind of research and do oversight really increases for Congress. That is going to be, not necessarily intention, but is another lane to be focused on while also building these future focused policy inroads. So it's sort of managing the present while also building policy for the future. Ben Palmer (15:14): So something I've been thinking about as we're talking about all of this is you mentioned how much bandwidth does this Congress have? I think there's going to be some big things that Democrats and Congress are going to tackle first. They're going to try and tackle enhanced ACA subsidies. They're going to try and tackle stuff within 03BA and stuff like that. (15:30): But some of these smaller things that we're mentioning I think could have more relevance, but there won't be as much fanfare around them. I think it's important to not confuse high political salience with high operational relevance for healthcare leaders. There may be some really loud debates about things that have less of an immediate impact than a payment rule or some kind of state Medicaid decision, or some of these, quote, unquote, "smaller things" that happen. That's kind of important to keep in mind. There will be those big things that will be their priorities, and we'll see how much they actually get to of everything. Abby Burns (17:23): There's another major domain of health policy that I want to talk about today that does not hinge on the results of the election last week necessarily, but I think is likely to be impacted by it. And that is what's happening with HR1, or the One Big Beautiful Bill Act. To start, what impact, if any, do you see this election having on HR1? Natalie Trebes (17:44): Well, Abby, a number of state governments changed hands and power. So there's either Republican trifectas now split state, split control, or split control states now fully Democrat trifecta. And so that kind of changes what is happening at the state level or possible at the state level with respect to implementation of OBBBA. And for those who maybe haven't thought about this in a couple months, most of HR1 or OBBBA, One Big Beautiful Bill, directs state level action. And so it is not a federal program, it's about how does the money go from the federal government to the states. While there is still a lot of regulation guidance to come out from HHS, and that's something that Congress will be highly active in overseeing, some of it has come out and states are making their progress on implementation. (18:33): That has a range of any flexibilities allowed. The states are making choices, and it's mostly are they going to go with the bare minimum restrictions, or are they going to be more restrictive? We had seen some GOP leaning states being more restrictive, but that might get dialed back down over time. And then the rest of it is kind of around resourcing decisions around how much are the states going to be investing in supporting enrollment efforts and maintenance of eligibility, and how are they going to adapt their budgets? Are they going to raise more taxes to pay for making up shortfalls, or are they going to just reduce benefits writ large? Abby Burns (19:08): And just for folks who aren't following One Big Beautiful Bill Act closely, some of the major provisions start taking effect in January of 2027. So Medicaid work requirements and eligibility checks start very beginning of next year. So the financial impacts are going to start hitting hospitals in particular very soon. Ben Palmer (19:23): Yeah, that's why I kind of think it's important for healthcare leaders to remember. They may have seen the results of the election, and say, "Oh, these things from HR1 are going to happen in the future, but maybe this election might change something." Maybe on the margins, there are some avenues in which changes to HR1 could happen or implementation of HR1. But I mean, I think the first thing to remember is that it is still law. It is still going to be law because there is no veto proof majority. But just because it is the Democrat's number one healthcare priority in the incoming Congress doesn't mean it's their easiest legislative accomplishment. It's going to take a lot of work. Natalie Trebes (20:00): And the messaging is going to be really hard for the Democrats, both at the state level and at the federal government. Work requirements is a great example. Effective January 1st probably starts to hit in April of 2027 because that's after you've gotten to the period where people start to get kicked off, and some people won't even find out until later in the year when they try to use healthcare and aren't covered. To the American people, if they're not paying attention, which is very fair and most of them aren't, that will look like the Democrats came in power and then I lost my Medicaid. Abby Burns (20:30): That's a good point. Natalie Trebes (20:31): So that is going to be a really complicated whole dynamic for the Democrats to navigate. Ben Palmer (20:37): Yeah, that's why I think some of these must pass legislative, like a budget fight specifically. I don't see a repeal of some of these Medicaid work requirements or Medicaid cuts, or whatever happening, but you could see maybe some way in which things are delayed, or implementation is slightly altered or changed so that this doesn't happen, and Democrats don't end up with that messaging of, hey, we all just lost our Medicaid coverage right after the Democrats came in power. Abby Burns (21:01): Recognizing that we just said these are a lot of policy areas for Congress, for policymakers to be dealing with, we are speaking directly to healthcare leaders who also need to be contending with all of these different dynamics, policy areas, impacts to their business. What do you want healthcare leaders to do coming out of this conversation, coming out of the midterm elections? Ben Palmer (21:25): First off, separate out the noise, separate the legal change from what is political noise. Ask whether something actually became law, or just became more politically likely or simply just became louder after the election happened. I think it's also important. We were mentioning states, six different states now flipped into statewide Democratic partisan trifectas. I think it's important to pay attention to what's happening in your state, map your exposure by your geography, certainly with implementation of HR1 as we mentioned. And then keep preparing. HR1 is still law. Continue preparing for the implementation. Things may change around the margins on it, but still keep getting ready for those cuts, for any kind of Medicaid cuts, work requirements, stuff like that. That's going to happen in some form or another. Natalie Trebes (22:14): And while you're doing that, be thinking about how you can capture evidence of how either policies affect your business or how your actions affected the implementation of those policies. So if you dedicated a case manager to helping with Medicaid eligibility redeterminations, how did that translate to the percentage of people who were able to redetermine, and back to your overall business and truly your community impact? (22:44): One of the things that really jumped out to me over the last year or so as we talked with leaders about the One Big Beautiful Bill Act and ramifications, as many people said, how did this happen and why is Congress not listening to us when we tell them if you do this, this is what will happen to your hospitals? And it is the opacity of our industry. We've really not, and many leaders admitted this, have not done a good job with clearly communicating to the broader public in a way that's kind of politically palatable. Because we get so into the technical weeds, and we're working with any one staffer in our office, and we need to also think about how do we message at that big picture because Congress just stopped wanting to hear it from us. (23:22): And so work with your local university to set up some sort of kind of study design to help you measure this so that we are equipped for this next era of health reform that I do believe we are heading into to have conversations that understand those long-term trickle effects and interconnection in the community. And I think the outcome of the election in Congress, especially in the Senate, there is a big enough margin that it's not quite veto proof, but it's enough margin that there will be some votes peeling off. And so I think there will be a decent amount of Democratic infighting intentions, especially gearing up towards a presidential run. And so the more that we can come to our representatives with clear evidence that cuts through, that will be helpful in helping them navigate what is going to be intra-party debate. Abby Burns (24:11): I think that's a really good point because it's not just a storytelling issue, right? It is a show me the numbers issue. And like you said, how can we prove the impact of policy matters, countermeasures, et cetera. To close this out, I know you all are both close followers of policy, health policy specifically. What are you personally watching or thinking most about looking forward? Ben Palmer (24:35): We were talking a lot about how the results of the midterms will also affect what happens in the 2028 presidential election. I think we just had an affordability election. Healthcare is part of that. It wasn't necessarily a healthcare election, indirectly perhaps. But healthcare is one of the biggest household affordability issues. And over the next two years with the implementation of all the things that are happening within O3BA, voters are going to see those effects. (25:01): And I think that will make 2028 a healthcare election more specifically than just an affordability election. I think by 2028, voters won't just be debating what these policies might do in the future. There's going to be evidence about what they have already done, and I think that's going to be top of mind. So that's kind of what I'm watching is how politically salient healthcare specifically becomes. It was an issue before. Now I think it may become the issue over the next two years. Abby Burns (25:32): All right, Ben, we'll check back in with you in two years, November 2028, see if you were right. Ben Palmer (25:37): Perfect. Abby Burns (25:38): Natalie, how about you? Natalie Trebes (25:40): Oh, so many things to watch, but I think out of the start, besides who's controlling what committees, I would be watching how much do the Democrats approach the oversight efforts with cheap shots and showmanship, which may be needed in certain places, versus alignment with the what can we actually get done and how does subpoenaing this particular official help us make the case for what changes we need to make to a delay on a rule or something like that. Abby Burns (26:09): Natalie, Ben, thank you both for coming on Radio Advisory. Ben Palmer (26:13): Thank you for having me. Natalie Trebes (26:13): Thank you. We'll see you in two years. Ben Palmer (26:15): Yeah. Abby Burns (26:21): This election gave us the answers of who will be in power for the next two years. And while that gives us some pretty workable theories on things like how policy priorities will shift and what oversight might look like, the ripple effects on healthcare business are a little less clear. (26:35): The things that are sticking with me from this conversation, one, this election was consequential, not transformational for healthcare. Or maybe to quote Natalie, it was consequential to set us up for potential transformation. Two, we're likely to see policy activity in the form of message bills that are likely to get vetoed, budget fights around must pass legislation, and even some movement on bipartisan areas of focus like transparency. Three, thorny areas like AI and Medicare Advantage are going to continue to occupy plenty of the precious mental bandwidth policymakers have. And finally, along those same lines, the One Big Beautiful Bill Act marches on. Maybe there are some delays here or there, that remains to be seen, but this is something leaders need to keep planning and bracing for. Ben and Natalie gave some clear advice for what to do in the near term. Because remember, as always, we're here to help. (27:30): If you like Radio Advisory, please share it with your networks, subscribe wherever you get your podcasts, and leave a rating and a review. Radio Advisory is a production of Advisory Board. This episode was produced by Chloe Bakst, Chris Phelps, Katy Anderson, and me, Abby Burns. The episode was edited also by Katy Anderson, with technical support provided by Dan Tayag, Chris Phelps, and Joe Shrum. We'll see you next week.